| Australian Ethical Investment Limited (AEF) ORDINARY FULLY PAID |
Financials |
$516 |
AEF - Appendix 3Z Kate Greenhill
|
31 Oct 2025 8:24AM |
$7.010 |
$4.530 |
fallen by
35.38%
|
|
| Origin Energy Limited (ORG) ORDINARY FULLY PAID |
Utilities |
$21,328 |
September 2025 Quarterly Report
|
31 Oct 2025 8:23AM |
$12.600 |
$12.380 |
fallen by
1.75%
|
|
| Flagship Minerals Limited (FLG) ORDINARY FULLY PAID |
Materials |
$71 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 8:23AM |
$0.195 |
$0.220 |
risen by
12.82%
|
|
FLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant focus on Pantanillo Gold Project with historical dataset acquisition from Anglo.
- Net cash used in operating activities of $(151)k for the current quarter.
- Net cash used in investing activities $(57)k, primarily for exploration and evaluation.
- Financing activities yielded $150k net cash inflow.
- Strategic partnership established with Xinhai for EPC services.
- Available funding at quarter end totaled $6,697k.
- Expected positive impact from ongoing metallurgical test work and resource expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$30 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Oct 2025 8:21AM |
$0.053 |
$0.046 |
fallen by
13.21%
|
|
QML - Price-sensitive ASX Announcement
Full Release
Key Points
- Confirmed high-grade copper-zinc mineralization at Develin Creek
- Completed $7.5 million placement and $1.5 million share purchase plan
- Net cash outflow from operating activities reported
- Estimated quarters of funding available less than one
- Plans to raise additional funds through a two-tranche placement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pinnacle Minerals Limited (PIM) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activity and Cashflow Report
|
31 Oct 2025 8:21AM |
$0.145 |
$0.048 |
fallen by
66.90%
|
|
PIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Capital raising of $1,760,000 with an additional $440,000 raised in August 2025.
- Cash and equivalents at the end of the quarter were approximately AUD $583,000.
- Acquisition of eight USA-located critical minerals, gold, and silver projects.
- Exploration activities commenced in Idaho and Washington State.
- Intention to list on the US-based OTCQB market announced.
- Fieldwork mobilization and geological consulting were key expenditure areas.
- Focus on expanding exploration in US critical minerals and Australian asset strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$14 |
Q1 FY26 Financial Performance & Business Update Presentation
|
31 Oct 2025 8:19AM |
$0.078 |
$0.033 |
fallen by
57.69%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Cluey Ltd reported a revenue of $7.4 million for Q1 FY26, with no change from the prior corresponding period.
- The company achieved its strongest-ever underlying EBITDA result, improving by 15% on the prior corresponding period.
- Cluey invested significantly in AI-driven product development to enhance its offerings for the 2026 academic year.
- Operating cash flow was recorded at -$0.4 million, a slight improvement from the previous period.
- There was a 9% decrease in new students and a 5% decrease in student sessions compared to the prior corresponding period.
- Variable customer acquisition cost per new student increased by 17%.
- Cluey is focusing on building a hybrid AI-and-human learning platform and expanding into a broader learning-services business.
- The company is developing an omnichannel learning network to integrate online and offline experiences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Capstone Copper Corp. (CSC) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$1,800 |
Ancillary Documents to Q3 2025 Financial Statements
|
31 Oct 2025 8:19AM |
$13.360 |
$10.320 |
fallen by
22.75%
|
|
| Capstone Copper Corp. (CSC) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$1,800 |
Q3 2025 Condensed Interim Financial Statements
|
31 Oct 2025 8:19AM |
$13.360 |
$10.320 |
fallen by
22.75%
|
|
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$498 |
September 2025 Quarterly Activities Report
|
31 Oct 2025 8:19AM |
$4.700 |
$5.920 |
risen by
25.96%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kiniero Gold Project in Guinea on track for first gold pour in Q4 2025.
- Nampala Gold Mine in Mali produced 9,774 ounces in Q3 2025.
- Merger with Predictive Discovery announced to enhance market position.
- C$148.2 million raised through warrant exercises.
- Continued focus on community engagement and environmental practices.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$67 |
Update - Notification of buy-back - BOL
|
31 Oct 2025 8:19AM |
$1.425 |
$1.700 |
risen by
19.30%
|
|
| Capstone Copper Corp. (CSC) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$1,800 |
Q3 2025 MD&A for Period Ended September 30, 2025
|
31 Oct 2025 8:19AM |
$13.360 |
$10.320 |
fallen by
22.75%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$121 |
Amplia Commences Trading on U.S. OTCQB Venture Market
|
31 Oct 2025 8:19AM |
$0.135 |
$0.235 |
risen by
74.07%
|
|
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$200 |
Update - Notification of buy-back - ATA
|
31 Oct 2025 8:18AM |
$0.715 |
$0.540 |
fallen by
24.48%
|
|
| Knosys Limited (KNO) ORDINARY FULLY PAID |
Information Technology |
$5 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 8:18AM |
$0.030 |
$0.022 |
fallen by
26.67%
|
|
KNO - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong quarterly cash receipts of $3.5 million.
- Annual Recurring Revenue (ARR) stood at $9.5 million.
- Positive operating cash flow of $0.6 million.
- Cash balance at 30 September 2025 was $3.4 million.
- Continued investment in product development, especially Libero X.
- Secured four new Libero contracts.
- Appointment of Dr. Phillip Carter as new Chair.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$51 |
Notification of cessation of securities - DOC
|
31 Oct 2025 8:18AM |
$0.155 |
$0.140 |
fallen by
9.68%
|
|
| Capstone Copper Corp. (CSC) CDI 1:1 FOREIGN EXEMPT TSX |
Materials |
$1,800 |
Capstone Copper Reports Third Quarter 2025 Results
|
31 Oct 2025 8:18AM |
$13.360 |
$10.320 |
fallen by
22.75%
|
|
CSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue reached an all-time high in Q3 2025.
- Record-low C1 cash costs achieved.
- Adjusted EBITDA reached $249.2 million.
- Net income attributable to shareholders was $248.1 million.
- Copper production totaled 55,280 tonnes, up 16% from Q3 2024.
- Mantoverde Optimized project was sanctioned for expansion.
- Capstone announced a joint venture with Orion Resource Partners.
- Water constraints affected Pinto Valley's operations.
- The company continues to focus on operational excellence and exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$396 |
Update - Notification of buy-back - PE1
|
31 Oct 2025 8:18AM |
$1.325 |
$1.480 |
risen by
11.70%
|
|
| Australian Ethical Investment Limited (AEF) ORDINARY FULLY PAID |
Financials |
$516 |
AEF - Resignation of Kate Greenhill
|
31 Oct 2025 8:18AM |
$7.010 |
$4.530 |
fallen by
35.38%
|
|
| Resources & Energy Group Limited (REZ) ORDINARY FULLY PAID |
Materials |
$12 |
Notice of Annual General Meeting/Proxy Form
|
31 Oct 2025 8:18AM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$14 |
September 2025 Quarterly Activities Report and Appendix 4C
|
31 Oct 2025 8:17AM |
$0.078 |
$0.033 |
fallen by
57.69%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Cluey Ltd reported its strongest-ever underlying EBITDA result in Q1 FY26.
- Operating cash flow improved by 20% compared to the prior corresponding period.
- Total cash on hand was $4.1 million as of 30 September 2025.
- Cash receipts from customers were $8.1 million, a 1% increase compared to the prior corresponding period.
- Cash payments for advertising and marketing decreased by 15% compared to the prior corresponding period.
- Cluey is investing in product development and AI-powered features for 2026.
- The company focuses on cost management and a product and marketing-led strategy for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,799 |
Notification of cessation of securities - MFG
|
31 Oct 2025 8:17AM |
$9.910 |
$9.810 |
fallen by
1.01%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,799 |
Update - Notification of buy-back - MFG
|
31 Oct 2025 8:17AM |
$9.910 |
$9.810 |
fallen by
1.01%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$18,465 |
Dividend/Distribution - RMD
|
31 Oct 2025 8:17AM |
$38.890 |
$32.160 |
fallen by
17.31%
|
|
| ResMed Inc. (RMD) CDI 10:1 FOREIGN EXEMPT NYSE |
Health Care |
$18,465 |
Resmed Announces Results for the First Quarter of FY2026
|
31 Oct 2025 8:17AM |
$38.890 |
$32.160 |
fallen by
17.31%
|
|
RMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 9% to $1.3 billion, up 8% on a constant currency basis.
- Gross margin improved by 290 basis points to 61.5%, with a non-GAAP margin of 62.0%.
- Income from operations rose by 15%, with non-GAAP income from operations up by 19%.
- Net income for the quarter was $349 million, and diluted earnings per share was $2.37, with non-GAAP diluted earnings per share at $2.55.
- Operating cash flow for the quarter was $457 million.
- The company declared a quarterly dividend of $0.60 per share.
- Revenue growth was driven by strong demand for sleep devices and accessories.
- The company recorded $16 million in restructuring charges due to workforce planning aligned with its 2030 strategic priorities.
- Capital management activities included $88 million in dividends paid and repurchase of 523,000 shares.
- Resmed received dual Red Dot Product Design 2025 awards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Oct 2025 8:17AM |
$0.023 |
$0.032 |
risen by
39.13%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Bio-Gene Technology Ltd focused on Flavocide and Qcide development.
- Flavocide showed more than 90% mortality against Ixodes scapularis ticks.
- Qcide's 14th harvest was completed with optimized yield.
- US Department of Defense funding for Flavocide and Qcide programs.
- A$2.46m raised through Placement and Share Purchase Plan.
- Strategic partnerships and product applications continue to expand.
- Estimated 0.98 quarters of funding available based on current cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.